216 related articles for article (PubMed ID: 1464870)
1. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations.
Kraus A; Caballero-Uribe C; Jakez J; Villa AR; Alarcón-Segovia D
J Rheumatol; 1992 Oct; 19(10):1572-4. PubMed ID: 1464870
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon in primary Sjögren's syndrome.
Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
[TBL] [Abstract][Full Text] [Related]
3. Sjogren's syndrome in SLE: Part I. The frequency of the clinical and subclinical features of Sjogren's syndrome in patients with SLE.
Grennan DM; Ferguson M; Williamson J; Mavrikakis M; Dick WC; Buchanan WW
N Z Med J; 1977 Oct; 86(598):374-6. PubMed ID: 272546
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon.
Willeke P; Schlüter B; Schotte H; Domschke W; Gaubitz M; Becker H
Semin Arthritis Rheum; 2009 Dec; 39(3):197-202. PubMed ID: 18571695
[TBL] [Abstract][Full Text] [Related]
5. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon in primary Sjögren's syndrome.
Youinou P; Pennec YL; Katsikis P; Jouquan J; Fauquert P; Le Goff P
Br J Rheumatol; 1990 Jun; 29(3):205-7. PubMed ID: 2357503
[TBL] [Abstract][Full Text] [Related]
7. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
8. Arthritis mutilans, tumoral calcinosis, Raynaud's phenomenon and Sjögren's syndrome.
Monteagudo M; Lima J; Bravo ML; García-Bragado F; Lience E; Vilardell M; Arnal MC
Br J Rheumatol; 1990 Aug; 29(4):303-5. PubMed ID: 2379048
[TBL] [Abstract][Full Text] [Related]
9. Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.
García-Carrasco M; Sisó A; Ramos-Casals M; Rosas J; de la Red G; Gil V; Lasterra S; Cervera R; Font J; Ingelmo M
J Rheumatol; 2002 Apr; 29(4):726-30. PubMed ID: 11950013
[TBL] [Abstract][Full Text] [Related]
10. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
[TBL] [Abstract][Full Text] [Related]
11. [Primary segmental sclerosing cholangitis associated with Sjögren's syndrome].
Guerrero P; Martín M; Conde JM; Castro M; Rodríguez MC; Castilla L; Guillén P
Rev Esp Enferm Dig; 1991 May; 79(5):363-6. PubMed ID: 1867927
[TBL] [Abstract][Full Text] [Related]
12. [Sjögren's syndrome in systemic scleroderma].
Guseva NG; Simonova MV; Kirtava ZZ; Shcherbakov AB
Ter Arkh; 1988; 60(4):54-6. PubMed ID: 3394099
[TBL] [Abstract][Full Text] [Related]
13. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatoid arthritis and Sjögren's syndrome. Special reference to the course time of rheumatoid arthritis].
Martínez Castro E; Olivé Marqués A; Bonet Llorach M; Carbonell Abellò J; Cobo Valeri E; Juncà Valdor S
Med Clin (Barc); 1990 May; 94(17):655-9. PubMed ID: 2200936
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance.
Font J; Ramos-Casals M; Cervera R; Bosch X; Mirapeix E; García-Carrasco M; Morlà RM; Ingelmo M
Br J Rheumatol; 1998 Dec; 37(12):1287-91. PubMed ID: 9973150
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
[TBL] [Abstract][Full Text] [Related]
17. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome.
Downie-Doyle S; Bayat N; Rischmueller M; Lester S
Arthritis Rheum; 2006 Aug; 54(8):2434-40. PubMed ID: 16869018
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
[TBL] [Abstract][Full Text] [Related]
20. Myositis in primary Sjögren's syndrome. Report of 3 cases.
Kraus A; Cifuentes M; Villa AR; Jakez J; Reyes E; Alarcón-Segovia D
J Rheumatol; 1994 Apr; 21(4):649-53. PubMed ID: 8035388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
